LB-2Avian Influenza A/H7N9 Vaccine Mixed with MF59 Adjuvant at the Point-of-Use. A Randomized Clinical Trial of a Pandemic Threat Response. (December 2014) - Mulligan, Mark J.; Bernstein, David; Winokur, Patricia; Rupp, Richard; Lai, Lilin; Anderson, Evan J.; Rouphael, Nadine; Dickey, Michelle; Stapleton, Jack T.; Edupuganti, Srilatha; Spearman, Paul W.; Kabbani, Sarah; et al.